About Contact Us Careers

Long-acting Beta-agonists Market Trends

Request Free Sample Copy

Report ID: 3996
Published Date: Aug 20, 2024
Report Format: PDF, PPT

Buy Now

Long-acting Beta-agonists Market Trends

Growth Drivers

Increasing Prevalence of Asthma and COPD
Growing Geriatric and Pediatric Population

Challenges

Side Effects of Bronchodilators
Government Restrictions regarding the Safety of the Drugs

Long-acting Beta-agonists Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	14.4%
Base Year Market Size (2023)	USD 987.4 million
Forecast Year Market Size (2036)	USD 5.67 billion
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Long-acting Beta-agonists Market Size, Forecast Report 2036

Author Credits: Radhika Pawar

Report ID: 3996
Published Date: Aug 20, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of long-acting beta-agonists is evaluated at USD 1.1 billion.

Long-acting Beta-agonists Market size was valued at USD 987.4 million in 2023 and is expected to reach USD 5.67 billion by 2036, expanding at around 14.4% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of asthma and COPD globally is anticipated to boost the market growth.

Asia Pacific industry is expected to hold largest revenue share by 2036, driven by high prevalence of COPD, bronchospasm, and other disorders amongst the geriatric population.

The major players in the market are GlaxoSmithKline plc, Merck KGaA, Mylan N.V., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Sumitomo Dainippon Pharma Co., Ltd., Koninklijke Philips N.V., Pear Therapeutics, Inc., and Sanofi-aventis Groupe.

Inquiry Before Buying Request Free Sample